• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿石症:结石形成者代谢评估的最新进展。

Urolithiasis: Update on Metabolic Evaluation of Stone Formers.

作者信息

Park Sangtae, Pearle Margaret S

机构信息

Department of Urology, The University of Texas Southwestern Medical Center, Dallas, Texas, USA.

出版信息

ScientificWorldJournal. 2005 Nov 11;5:902-914. doi: 10.1100/tsw.2005.118. eCollection 2005.

DOI:10.1100/tsw.2005.118
PMID:29861685
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5936501/
Abstract

Metabolic abnormalities are identified in over 90% of stone formers and the institution of preventative dietary and medical measures has resulted in substantial reduction in stone recurrence rates. We review the contemporary approach to metabolic evaluation of urolithiasis. A careful medical and dietary history, stone analysis, serologic tests, and urinalysis constitute the initial screening regimen in patients who have been diagnosed with stones. Risk stratification of patients, based on the outcome of the initial screening tests, determines the need for and extent of urinary evaluation in individual stone formers. Conservative dietary measures or a simple metabolic evaluation and treatment has been described for first-time or low-risk stone formers, although the number of 24-h urine collections needed is debatable. A more extensive metabolic evaluation is recommended for recurrent or high-risk stone formers or for those in whom empiric treatment or medical therapy based on simplified evaluation is unsuccessful. Regardless of etiology, all stone formers should be counseled on dietary measures for stone prevention. The need for medication is determined by the results of 24-h urine analysis and the risk level of the patient. Cost effectiveness of the metabolic evaluation and treatment is strongly influenced by recurrence rate and efficacy of therapy. Metabolic evaluation and treatment has clearly been shown in randomized trials to reduce stone recurrence rates. Further study will determine the extent of evaluation necessary and the need for selective vs. empiric medical therapy for first-time and recurrent stone formers.

摘要

超过90%的结石患者存在代谢异常,而采取预防性饮食和医学措施已使结石复发率大幅降低。我们回顾了当前对尿石症进行代谢评估的方法。详细的病史和饮食史、结石分析、血清学检查及尿液分析构成了已确诊结石患者的初始筛查方案。根据初始筛查结果对患者进行风险分层,可确定个体结石患者尿液评估的必要性和范围。对于首次发病或低风险结石患者,已有人描述了保守的饮食措施或简单的代谢评估与治疗方法,不过所需的24小时尿液收集次数仍存在争议。对于复发或高风险结石患者,或基于简化评估的经验性治疗或药物治疗未成功的患者,建议进行更全面的代谢评估。无论病因如何,都应向所有结石患者提供预防结石的饮食措施建议。是否需要用药由24小时尿液分析结果和患者的风险水平决定。代谢评估与治疗的成本效益受复发率和治疗效果的强烈影响。随机试验已明确表明,代谢评估与治疗可降低结石复发率。进一步的研究将确定所需评估的程度,以及首次发病和复发结石患者进行选择性治疗与经验性药物治疗的必要性。

相似文献

1
Urolithiasis: Update on Metabolic Evaluation of Stone Formers.尿石症:结石形成者代谢评估的最新进展。
ScientificWorldJournal. 2005 Nov 11;5:902-914. doi: 10.1100/tsw.2005.118. eCollection 2005.
2
Cost-effectiveness of medical management strategies for nephrolithiasis.肾结石病医疗管理策略的成本效益
J Urol. 2004 Dec;172(6 Pt 1):2275-81. doi: 10.1097/01.ju.0000141498.11720.20.
3
Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines.代谢评估和预防尿路结石患者复发:EAU 指南。
Eur Urol. 2015 Apr;67(4):750-63. doi: 10.1016/j.eururo.2014.10.029. Epub 2014 Nov 20.
4
International comparison of cost effectiveness of medical management strategies for nephrolithiasis.肾结石医疗管理策略成本效益的国际比较
Urol Res. 2005 Jun;33(3):223-30. doi: 10.1007/s00240-005-0463-9. Epub 2005 May 28.
5
Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.肾结石形成的尿液危险因素的饮食治疗。CLU工作组综述
Arch Ital Urol Androl. 2015 Jul 7;87(2):105-20. doi: 10.4081/aiua.2015.2.105.
6
Metabolic Work-up of Patients with Urolithiasis: Indications and Diagnostic Algorithm.代谢性结石患者的检查:适应证和诊断算法。
Eur Urol Focus. 2017 Feb;3(1):62-71. doi: 10.1016/j.euf.2017.03.014. Epub 2017 Apr 7.
7
Abnormalities of 24-hour urine composition in first-time and recurrent stone-formers.首次和复发性结石形成者 24 小时尿液成分的异常。
Urology. 2012 Oct;80(4):776-9. doi: 10.1016/j.urology.2012.06.034. Epub 2012 Aug 22.
8
Urinary risk factors for recurrent calcium stone formation in Thai stone formers.泰国结石患者复发性钙结石形成的尿液危险因素。
J Med Assoc Thai. 2007 Apr;90(4):688-98.
9
Urinary metabolic evaluations in solitary and recurrent stone forming children.孤立性和复发性结石形成儿童的尿液代谢评估
J Urol. 2008 Jun;179(6):2369-72. doi: 10.1016/j.juro.2008.01.151. Epub 2008 Apr 23.
10
[Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].[钙肾结石的病理生理学、诊断及保守治疗]
Ther Umsch. 2003 Feb;60(2):79-87. doi: 10.1024/0040-5930.60.2.79.

引用本文的文献

1
Perioperative Complications in Percutaneous Nephrolithotomy: Predictive Risk Factors and Hemodynamic Alterations.经皮肾镜取石术围手术期并发症:预测风险因素及血流动力学改变
Cureus. 2024 Sep 15;16(9):e69488. doi: 10.7759/cureus.69488. eCollection 2024 Sep.
2
Comparison of complications associated with standard and totally tubeless percutaneous nephrolithotomy according to modified Clavien grading: a multicenter retrospective study.根据改良Clavien分级比较标准经皮肾镜取石术与完全无管经皮肾镜取石术相关并发症:一项多中心回顾性研究
Kaohsiung J Med Sci. 2014 Dec;30(12):613-8. doi: 10.1016/j.kjms.2014.09.006. Epub 2014 Oct 25.